Circulating Tumor DNA in a Breast Cancer Patient's Plasma Represents Driver Alterations in the Tumor Tissue
Tumor tissues from biopsies or surgery are major sources for the next generation sequencing (NGS) study, but these procedures are invasive and have limitation to overcome intratumor heterogeneity. Recent studies have shown that driver alterations in tumor tissues can be detected by liquid biopsy whi...
Saved in:
| Main Authors: | Jieun Lee, Sung-Min Cho, Min Sung Kim, Sug Hyung Lee, Yeun-Jun Chung, Seung-Hyun Jung |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BioMed Central
2017-03-01
|
| Series: | Genomics & Informatics |
| Subjects: | |
| Online Access: | http://genominfo.org/upload/pdf/gni-15-48.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Circulating tumor DNA (ctDNA) Detection via electrochemical Biosensing Tools
by: Sonya Sahin, et al.
Published: (2024-06-01) -
Circulating Cell-free Tumor Nucleic Acids in Gastric Cancer
by: Hyun-Ji Lee, et al.
Published: (2018-09-01) -
Sirolimus treatment of a PTEN hamartoma tumor syndrome presenting with melena
by: Gülseren Evirgen Şahin, et al.
Published: (2022-08-01) -
Utility and Clinical Application of Circulating Tumor DNA (ctDNA) in Advanced Prostate Cancer
by: Louise Kostos, et al.
Published: (2023-07-01) -
Current Methods of Circulating Tumor Cell Detection
by: Minji Lim, et al.
Published: (2018-09-01)